Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission

Jingbo Zhou(Qingdao University), Jin Sun(Qingdao University), Ce Qi(Qingdao University), Huayu Tu(Qingdao University), Hong Chang(Qingdao University), Renqiang Yu(Jiangnan University), Jie Chen(Qingdao University), Xinyue Li(Beijing Institute of Education), Haoyu Li(Qingdao University), Gaoshun Xu(Qingdao University)
Frontiers in Nutrition
September 28, 2022
10.3389/fnut.2022.987400
Cited by 17

Related Papers

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway
|Frontiers in Cellular and Infection Microbiology|2020|111
Anti-Cancer Effect of Metabotropic Glutamate Receptor 1 Inhibition in Human Glioma U87 Cells: Involvement of PI3K/Akt/mTOR Pathway
|Cellular Physiology and Biochemistry|2015|80
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
|Diabetes Care|2023|80